Table 1 Pre-operative demographic and clinical characteristics of patients undergoing open abdominal aortic aneurysm repair with and without major adverse cardiovascular events at 30 days.

From: Predicting outcomes following open abdominal aortic aneurysm repair using machine learning

 

Absence of MACE at 30 days

(n = 3,309)

Presence of MACE at 30 days

(n = 311)

P

Demographics

Age, years, mean (SD)

70.2 (7.6)

72.7 (6.8)

< 0.001

Female

842 (25.4)

87 (28.0)

0.36

BMI, kg/m2, mean (SD)

27.8 (5.4)

27.3 (5.6)

0.13

Race

   

 White

2,074 (62.7)

187 (60.1)

0.82

 Black or African American

112 (3.4)

8 (2.6)

 American Indian or Alaskan Native

9 (0.3)

1 (0.3)

 Native Hawaiian or Other Pacific Islander

4 (0.1)

0

 Asian

53 (1.6)

7 (2.3)

 Other

2 (0.06)

0

 Unknown or not reported

1,055 (31.9)

103 (34.7)

Hispanic ethnicity

65 (2.0)

8 (2.6)

0.60

Origin status

   

 Transferred from another hospital

176 (5.3)

29 (9.3)

< 0.001

 Home

3,116 (94.2)

277 (89.1)

 Nursing home

12 (0.4)

5 (1.6)

 Other facility

3 (0.09)

0

 Unknown

2 (0.06)

0

Comorbidities

Hypertension

2,551 (77.1)

259 (83.3)

0.02

Diabetes

   

 Non-insulin dependent

355 (10.7)

29 (9.3)

0.49

 Insulin dependent

63 (1.9)

12 (3.9)

0.02

Current smoker

1,476 (44.6)

174 (55.9)

< 0.001

Congestive heart failure

42 (1.3)

10 (3.2)

0.01

Chronic obstructive pulmonary disease

574 (17.3)

85 (27.3)

< 0.001

Dialysis

15 (0.5)

3 (1.0)

0.42

Functional status

   

 Independent

3,262 (98.6)

303 (97.4)

0.26

 Partially dependent

42 (1.3)

8 (2.6)

 Totally dependent

4 (0.1)

0

 Unknown

1 (0.03)

0

ASA class

   

 1

4 (0.1)

0

< 0.001

 2

151 (4.6)

5 (1.6)

 3

1,775 (53.6)

139 (44.7)

 4

1,361 (41.1)

163 (52.4)

 5

12 (0.4)

4 (1.3)

 Unknown

6 (0.2)

0

Previous procedures

Open AAA repair

16 (0.5)

4 (1.3)

0.15

Endovascular AAA repair

282 (8.5)

48 (15.4)

< 0.001

Open abdominal surgery

866 (26.2)

80 (25.7)

0.92

Laboratory investigations

Sodium, mmol/L, mean (SD)

139.0 (3.0)

139.0 (3.2)

0.92

BUN, mmol/L, mean (SD)

51.0 (21.7)

57.1 (26.6)

< 0.001

Creatinine, umol/L, mean (SD)

96.4 (47.7)

107.9 (41.7)

< 0.001

Albumin, g/L, mean (SD)

34.9 (4.9)

34.7 (5.2)

0.56

White blood cell count, cells/mm3, mean (SD)

7.7 (2.3)

7.9 (2.8)

0.39

Hematocrit, L/L (%), mean (SD)

40.9 (5.1)

39.3 (5.4)

< 0.001

Platelet count, 109/L, mean (SD)

217.0 (66.3)

210.0 (85.8)

0.10

INR, mean (SD)

1.1 (0.2)

1.1 (0.2)

0.38

PTT, sec, mean (SD)

30.0 (5.6)

30.1 (5.1)

0.56

Anatomic characteristics

AAA diameter, cm, mean (SD)

6.2 (1.5)

6.4 (1.5)

0.02

Surgical approach

   

 Transperitoneal

2,608 (72.8)

238 (76.5)

0.32

 Retroperitoneal

851 (25.7)

70 (22.5)

 Not documented

50 (1.5)

3 (1.0)

Proximal AAA extent

   

 Suprarenal

192 (5.8)

30 (9.7)

0.005

 Pararenal

161 (4.9)

21 (6.8)

 Juxtarenal

951 (28.7)

100 (32.2)

 Infrarenal

1,817 (54.9)

141 (45.3)

 Not documented

188 (5.7)

19 (6.1)

Distal AAA extent

   

 Aorta

1,402 (42.4)

137 (44.1)

0.59

 Common iliac artery

1,214 (36.7)

111 (35.7)

 Internal iliac artery

103 (3.1)

5 (1.6)

 External iliac artery

134 (4.1)

15 (4.8)

 Not documented

456 (13.8)

43 (13.8)

Concomitant procedures

Renal revascularization

324 (9.8)

43 (13.8)

0.03

Visceral revascularization

76 (2.3)

15 (4.8)

0.01

Lower extremity revascularization

233 (7.0)

45 (14.5)

< 0.001

  1. Values are reported as No. (%) unless otherwise indicated.
  2. Abbreviations: MACE (major adverse cardiovascular event), BMI (body mass index), ASA (American Society of Anesthesiologists), AAA (abdominal aortic aneurysm), BUN (blood urea nitrogen), INR (international normalized ratio), PTT (partial thromboplastin time), SD (standard deviation).